相关实验视频
Updated: May 12, 2025

04:39
Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
Published on: March 17, 2023
1.5K
类风湿性关节炎和自身免疫性甲状腺疾病之间的干扰:双向的门德尔随机化
Yuman Yin1,2, Min Liao2, Yunfeng Yu1
1School of Traditional Chinese Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, China.
Medicine
|April 21, 2025
概括
类风湿性关节炎 (RA) 可能会增加自身免疫性甲状腺疾病 (AITD) 的风险,包括Graves病.
科学领域:
- 类风湿病学 类风湿病学
- 内分泌学 在内分泌学.
- 遗传流行病学遗传流行病学
背景情况:
- 类风湿性关节炎 (RA) 和自身免疫性甲状腺疾病 (AITD) 之间的病因联系尚未完全理解.
- 之前的研究对RA和AITD之间的关联产生了相互矛盾的结果.
- 遗传因素可能在这些自身免疫性疾病的同时出现中发挥作用.
研究的目的:
- 用双向门德尔随机化方法研究类风湿性关节炎和自身免疫性甲状腺疾病之间的潜在因果关系.
- 评估RA是否会增加AITD (特别是自身免疫性甲状腺炎和格雷夫斯病) 的风险,反之亦然.
主要方法:
- 使用双向门德尔随机化 (MR) 分析.
- 与RA,自身免疫性甲状腺炎 (AIT) 和格雷夫斯病 (GD) 相关的单核酸多态 (SNPs) 来自FinnGen数据库.
- 逆方差加权 (IVW) 方法用于初级分析,使用MR-Egger,Cochran Q和灵敏度分析来评估变性和异质性.
主要成果:
- 类风湿性关节炎与AIT (OR 1.552) 和GD (OR 1.177) 的风险增加显著相关.
- 格雷夫斯病与RA风险增加有显著关联 (OR 1.030),而AIT与RA风险没有显著关联 (OR 0.994).
- 核磁共振分析证实了强度,没有发现显著的水平形或异质性.
结论:
- 类风湿性关节炎可能是发展自身免疫性甲状腺疾病,特别是格雷夫斯病的危险因素.
- 格雷夫斯病也可能增加患类风湿性关节炎的风险.
- 建议在RA患者中对AITD和在GD患者中对RA进行主动查,以改善患者的治疗结果.
相关概念视频
Autoimmune Disorders
320
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
320
Genome-wide Association Studies-GWAS
12.1K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.1K
Synthesis and Regulation of Thyroid Hormones
3.9K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
3.9K
T Cell Types and Functions
627
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
627
The JAK-STAT Signaling Pathway
8.4K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.4K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
101
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
101

